Mark Leong – Executive Chairman – Osteopore (ASX:OSX) is a Singapore-headquartered corporation poised to be a leading medical device company in the region. It is involved in designing, developing and marketing bioresorbable polymer implants for neurosurgical, orthopedic, and maxillofacial surgery use.
Copyright 2023 – Finance News Network
Source: Finance News Network
20 Jul 2020 - BluGlass Limited (ASX:BLG) Managing Director and CEO Giles Bourne gives an update on the commissioning of the BLG 500 at Silverwater, strategic alliances and product roadmap.
Read More21 Sep 2021 - An introduction to newly appointed BluGlass Limited (ASX:BLG) President, Jim Haden.
Read More13 May 2025 - Cameron Cormack, Senior Portfolio Manager at VanEck, on ETF strategy and market outlook
Read More11 Apr 2023 - icetana Limited (ASX:ICE) CEO and Managing Director Matt Macfarlane discusses recent contracts and the company's new surveillance software.
Read More13 Mar 2020 - SUDA Pharmaceuticals Limited (ASX:SUD) CEO, Dr Michael Baker talks 1H20 results progress with the company's lead product Zolpimist, the spay version of Sanofi’s blockbuster insomnia drug Ambien and focus for 2020.
Read More29 Jul 2021 - BARD1 Life Sciences Limited (ASX:BD1) CEO Dr Leearne Hinch introduces the company, discussing its recent capital raising and share purchase plan.
Read More02 Jun 2021 - Next Science Limited (ASX:NXS) Managing Director Judith Mitchell talks about the company's antimicrobial wound gel BlastX, and its health benefits for the treatment of chronic wounds and ulcers.
Read More17 May 2024 - Elementos Limited (ASX:ELT) Managing Director Joe David discusses the recommencement of DFS and licensing activities following discussions with the Andalusian government.
Read More07 Dec 2020 - The Agency Group Australia Limited (ASX:AU1) Managing Director Paul Niardone talks FY20 results, strategy and outlook following the company's new funding package.
Read More03 Mar 2025 - Addressing Unmet Needs in Cancer Care
Read More
